Review of Cerebral Microangiopathy and Alzheimer’s Disease: Relation between White Matter Hyperintensities and Microbleeds

@article{Hommet2011ReviewOC,
  title={Review of Cerebral Microangiopathy and Alzheimer’s Disease: Relation between White Matter Hyperintensities and Microbleeds},
  author={C. Hommet and Karl Mondon and Thierry Constans and {\'E}milie Beaufils and Thomas Desmidt and Vincent Camus and Jean Philippe Cottier},
  journal={Dementia and Geriatric Cognitive Disorders},
  year={2011},
  volume={32},
  pages={367 - 378}
}
Although Alzheimer’s disease (AD) is basically considered to be a neurodegenerative disorder, cerebrovascular disease is also involved. The role of vascular risk factors and vascular disease in the progression of AD remains incompletely understood. With the development of brain MRI, it is now possible to detect small-vessel disease, whose prevalence and severity increase with age. The first types of small-vessel disease to be described were white matter hyperintensities (WMHs). More recently… 

Figures from this paper

Cerebral small vessel disease and Alzheimer’s disease
TLDR
There is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD.
Vascular factors in Alzheimer’s disease
TLDR
Patients with AD different stages showed the following changes in angioarchitectonics and microcirculation: absence of pronounced atherosclerotic lesions of intracranial vessels, reduction of the capillary bed in the temporal and temporo-parietal regions, development of multiple arteriovenous shunts in the same areas, early venous discharge.
Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit
TLDR
It is remarked that SVD and white matter abnormalities are seen frequently with aging and also that vascular and endothelium changes are related with age; the changes can be accelerated by different vascular risk factors.
Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?
TLDR
The possible mechanisms that lead a healthy aging process towards subcortical dementia are examined and it is remarked that SVD and white matter abnormalities related to age could be accelerated and potentiated by different vascular risk factors.
LARGE VESSEL CEREBROVASCULAR DISEASE AND DEMENTIA Intracranial atherosclerosis
TLDR
The global prevalence of dementia, particularly AD and VaD; risk factors for CVD and their contributory role; role of large vessel CVD in the progression of dementia; role and pathophysiology of cerebral small-vessel disease; and the current treatment and preventive measures are highlighted.
Pathology and pathogenesis of vascular cognitive impairment—a critical update
TLDR
Clinico-pathological studies and harmonization of neuropathological procedures are needed to validate the diagnostic criteria for VaD and mixed dementia in order to clarify the impact of CVLs and other coexistent pathologies on cognitive impairment as a basis for further successful therapeutic options.
Moving Away from Amyloid Beta to Move on in Alzheimer Research
TLDR
The brains of AD may have additional changes, such as (micro)vascular changes, white matter hyperintensities, and vacuolar cells, which are not considered as pathognomonic features under current standards (Nelson et al., 2012).
Correlation between Leukoaraiosis and natural brain tissue velocity: A pilot study using Ultrasound and MRI
TLDR
The main finding is that TPImax decreases significantly when the severity of LA increases, and the ultrasonic TPI method appears to be valuable and promising.
White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies
TLDR
It can be concluded that WM abnormalities are detectable in early stages of Alzheimer’s disease and mild cognitive impairment.
...
...

References

SHOWING 1-10 OF 188 REFERENCES
Cerebral microbleeds and vascular cognitive impairment
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
TLDR
In cases of Alzheimer's presenile and senile dementia, Alzheimer's disease (AD) andsenile dementia of the Alzheimer type (SDAT), respectively, a lesion that has the character of an incomplete infarction confined to the white matter is observed.
Cerebral microbleeds in Alzheimer’s disease
TLDR
T2*-weighted gradient-echo magnetic resonance imaging (MRI) scans were obtained to determine the frequency, extent, and pattern of MBs in patients with Alzheimer’s disease (AD), and MBs were defined on gradient- echo T2*weighted images as homogenous rounded lesions of signal loss with a diameter greater than 2 mm.
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.
TLDR
Novel evidence is provided that microbleeds are associated with cognitive dysfunction, independent of the extent of MRI-visible white matter changes of presumed ischaemic origin, or the presence ofIschaemic stroke.
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
TLDR
Pathological substrates of WMH are heterogeneous in nature and severity, which may partly explain the weak clinicoradiological associations found in SVD.
Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?
TLDR
Proof that blood-brain barrier failure is key to 3 overlapping and disabling cerebrovascular conditions could provide a target for new treatments to reduce the effects of vascular disease on the brain and prevent cognitive decline and dementia.
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
TLDR
Plasma β-amyloid 40 concentration is independently associated with extent of white matter hyperintensity in subjects with Alzheimer disease, mild cognitive impairment, or cerebral amyloid angiopathy, and if confirmed in longitudinal studies, these data would suggest circulating β-Amyloid peptide as a novel biomarker or risk factor for microvascular damage in these common diseases of the elderly.
Brain microbleeds and Alzheimer's disease: innocent observation or key player?
TLDR
The aim of this article is to review available data to understand the meaning of brain microbleeds in clinical terms and underlying pathology in the context of Alzheimer's disease and highlight the pitfalls of current knowledge on brain microbleds in the setting of clinical trials design.
Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study.
TLDR
Microbleeds were frequent, often multiple, and predicted greater leukoaraiosis and cognitive performance in Alzheimer disease patients, illustrating the complexity of AD vasculopathy and the need for additional studies in dementia and stroke populations.
...
...